SCHMID JOHN P. purchased 49.1% of their position (5.40K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market purchase worth $10.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/10/2024ACC: 0001867096-24-000067
Director
Since Oct 2021
+5.40K
Net shares
Net buyer
$10.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5.40K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+5.40K
Price / share
$1.91
Trade value
$10.31K
% of position
49.1%
5/10/2024
11K→16.40K
Total
Net shares
+5.40K
Net value
$10.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/10/2024 | P · Purchase | +5.40K | $1.91 | $10.31K | 49.1% | 11K | 16.40K |
| Total | +5.40K | $10.31K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned63.16K
Total
63.16K direct63.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 63.16K | Direct |
| Total | 63.16K | 63.16K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported